139 related articles for article (PubMed ID: 2190194)
1. Oral clindamycin and ciprofloxacin therapy for diabetic foot infections.
Sesin GP; Paszko A; O'Keefe E
Pharmacotherapy; 1990; 10(2):154-6. PubMed ID: 2190194
[TBL] [Abstract][Full Text] [Related]
2. Ciprofloxacin: a study of usage in pedal infections with case reports.
Notari MA; Mittler BE
J Foot Surg; 1989; 28(6):521-3. PubMed ID: 2630590
[TBL] [Abstract][Full Text] [Related]
3. Ciprofloxacin versus gentamicin/clindamycin for postpartum endometritis.
Maccato ML; Faro S; Martens MG; Hammill HA
J Reprod Med; 1991 Dec; 36(12):857-61. PubMed ID: 1816396
[TBL] [Abstract][Full Text] [Related]
4. Ciprofloxacin monotherapy for acute pelvic infections: a comparison with clindamycin plus gentamicin.
Thadepalli H; Mathai D; Scotti R; Bansal MB; Savage E
Obstet Gynecol; 1991 Oct; 78(4):696-702. PubMed ID: 1923175
[TBL] [Abstract][Full Text] [Related]
5. Double-blind comparison of ciprofloxacin with cefotaxime in the treatment of skin and skin structure infections.
Pérez-Ruvalcaba JA; Quintero-Pérez NP; Morales-Reyes JJ; Huitrón-Ramírez JA; Rodríguez-Chagollán JJ; Rodríguez-Noriega E
Am J Med; 1987 Apr; 82(4A):242-6. PubMed ID: 3555042
[TBL] [Abstract][Full Text] [Related]
6. Pharmacoepidemiology of ciprofloxacin: analysis of use patterns and cost impact.
Marchbanks CR; Graham KK; Barnes J; Dudley MN
Pharmacotherapy; 1991; 11(1):50-5. PubMed ID: 2020611
[TBL] [Abstract][Full Text] [Related]
7. Microbiology and antimicrobial therapy of diabetic foot infections.
Joseph WS; Axler DA
Clin Podiatr Med Surg; 1990 Jul; 7(3):467-81. PubMed ID: 2205347
[TBL] [Abstract][Full Text] [Related]
8. Anaerobic bacteria isolated from foot infections in diabetic patients: in vitro susceptibility to nine antibiotics.
Ginunas VJ; Canawati HN; Sapico FL
Clin Ther; 1984; 6(4):457-60. PubMed ID: 6467279
[TBL] [Abstract][Full Text] [Related]
9. Sequential intravenous/oral ciprofloxacin as an empiric antimicrobial therapy: results of a Canadian multicenter study. The Canadian Collaborative Investigational Group.
Davis C
Clin Ther; 1994; 16(3):505-21. PubMed ID: 7923317
[TBL] [Abstract][Full Text] [Related]
10. Oral ciprofloxacin vs parenteral cefotaxime in the treatment of difficult skin and skin structure infections. A multicenter trial.
Gentry LO; Ramirez-Ronda CH; Rodriguez-Noriega E; Thadepalli H; del Rosal PL; Ramirez C
Arch Intern Med; 1989 Nov; 149(11):2579-83. PubMed ID: 2684078
[TBL] [Abstract][Full Text] [Related]
11. Clindamycin and quinolone therapy for Bacillus anthracis Sterne infection in 60Co-gamma-photon-irradiated and sham-irradiated mice.
Brook I; Germana A; Giraldo DE; Camp-Hyde TD; Bolduc DL; Foriska MA; Elliott TB; Thakar JH; Shoemaker MO; Jackson WE; Ledney GD
J Antimicrob Chemother; 2005 Dec; 56(6):1074-80. PubMed ID: 16239289
[TBL] [Abstract][Full Text] [Related]
12. Management and outcome of severe diabetic foot infections.
Diamantopoulos EJ; Haritos D; Yfandi G; Grigoriadou M; Margariti G; Paniara O; Raptis SA
Exp Clin Endocrinol Diabetes; 1998; 106(4):346-52. PubMed ID: 9792469
[TBL] [Abstract][Full Text] [Related]
13. Use of ciprofloxacin in the treatment of hospitalized patients with intra-abdominal infections.
Madan AK
Clin Ther; 2004 Oct; 26(10):1564-77. PubMed ID: 15598473
[TBL] [Abstract][Full Text] [Related]
14. Oral ciprofloxacin versus intravenous therapy with other non-quinolone agents: a study of 291 infections.
Lorian V; Pavletich K
Drugs Exp Clin Res; 1994; 20(5):209-14. PubMed ID: 7875058
[TBL] [Abstract][Full Text] [Related]
15. Comparison of parenteral ciprofloxacin with clindamycin-gentamicin in the treatment of pelvic infection.
Apuzzio JJ; Stankiewicz R; Ganesh V; Jain S; Kaminski Z; Louria D
Am J Med; 1989 Nov; 87(5A):148S-151S. PubMed ID: 2589359
[TBL] [Abstract][Full Text] [Related]
16. Clindamycin unresponsive anaerobic osteomyelitis treated with oral metronidazole.
Zimmerman J; Silver J; Shapiro M; Friedman G; Melmed RN
Scand J Infect Dis; 1980; 12(1):79-80. PubMed ID: 7367840
[TBL] [Abstract][Full Text] [Related]
17. Outpatient management of uncomplicated lower-extremity infections in diabetic patients.
Lipsky BA; Pecoraro RE; Larson SA; Hanley ME; Ahroni JH
Arch Intern Med; 1990 Apr; 150(4):790-7. PubMed ID: 2183732
[TBL] [Abstract][Full Text] [Related]
18. Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate.
Lipsky BA; Itani K; Norden C;
Clin Infect Dis; 2004 Jan; 38(1):17-24. PubMed ID: 14679443
[TBL] [Abstract][Full Text] [Related]
19. Systemic treatment of cutaneous infections. A comparative study of ciprofloxacin and cefotaxime.
Parish LC; Asper R
Am J Med; 1987 Apr; 82(4A):227-9. PubMed ID: 3555041
[TBL] [Abstract][Full Text] [Related]
20. Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection.
de Lalla F; Pellizzer G; Strazzabosco M; Martini Z; Du Jardin G; Lora L; Fabris P; Benedetti P; Erle G
Antimicrob Agents Chemother; 2001 Apr; 45(4):1094-8. PubMed ID: 11257020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
